Shionogi & Co., Ltd. is a leading pharmaceutical company in Japan, established in June 1919, mainly engaged in the development and sales of pharmaceutical products, with annual sales of 28.2 billion yen (FY2010), listed on the Tokyo and Osaka stock exchanges. In August 2011, it became the controlling shareholder of C&O.